Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > No one can predict when or if approvals will happen.

<< Previous

Bullboard Posts

Next >>

Comment by Kingofstockston Sep 20, 2021 8:35am

133 Views

Post# 33885701

RE:No one can predict when or if approvals will happen.

You get the award for dumbest comment on the internet.... congrats and if it was selling pressure we would of been red you genius of a human.... on the future nobody can guarantee anything 100% but the odds are in out favor and the best is yet 2 come .. glta

<< Previous

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading